Doctor profile · Federal record

Dr. Viraj Shroff-Mehta, MD

Clinical & Laboratory Dermatological Immunology Physician (CMS: Dermatology) · North Easton, MA

  • NPI 1508838525
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 31 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
31 Roche Bros Way, Suite 200
North Easton, MA 023561032
(508) 535-3376
fax (508) 535-3377

Credentials & registration

NPPES · NUCC
NPI registered
February 2006 — 20 yrs on file
Profile last updated
March 16, 2009
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207NI0002X — NUCC code
State license (1)
Massachusetts #160425
Medicaid
MA #3196798

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1508838525. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,748
Distinct HCPCS
10
Medicare allowed
$247,004
HCPCS Description Services Patients Avg allowed
99213 Established patient office or other outpatient visit, 20-29 minutes 1,128 831 $92
17003 Destruction of precancer skin growth, 2-14 growths 1,105 223 $7
17000 Destruction of precancer skin growth, 1 growth 409 301 $58
11102 Biopsy of related skin growth, first growth 317 260 $104
11103 Biopsy of related skin growth, each additional growth 157 98 $53
99214 Established patient office or other outpatient visit, 30-39 minutes 155 132 $131
99212 Established patient office or other outpatient visit, 10-19 minutes 144 134 $58
17110 Destruction of skin growth, 1-14 growths 140 130 $117
99203 New patient office or other outpatient visit, 30-44 minutes 50 50 $114
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 33 25 $158

In context: peer comparison

Among 1 peers in North Easton Clinical & Laboratory Dermatological Immunology Physician, average services per provider: 220. This provider delivers 17× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$429
Transactions
16
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
Revance Therapeutics, INC. 2 $78.24
Ucb, INC. 1 $74.94
Arcutis Biotherapeutics, INC. 2 $41.94
Galderma Laboratories, L.P. 2 $38.44
E.R. Squibb & Sons, L.L.C. 2 $37.68
Abbvie INC. 1 $34.57
Biofrontera INC. 2 $34.16
Leo Pharma INC. 1 $28.85
Ortho Dermatologics, A Division of Bausch Health US, LLC 1 $23.76
Amgen INC. 1 $22.22
Sun Pharmaceutical Industries INC. 1 $13.79

By nature of payment

Food and Beverage
$429

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
648
Patients
362
Total drug cost
$182,035
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 102 86 $814
Ketoconazole Generic 84 63 $1,750
Betamethasone Dipropionate Generic 63 24 $2,183
Clobetasol Propionate Generic 61 31 $3,422
Doxycycline Hyclate Generic 45 14 $1,159
Fluorouracil Generic 43 41 $2,812
Metronidazole Generic 43 28 $2,936
Otezla (Apremilast) Brand 35 0 $163,538
Valacyclovir (Valacyclovir Hcl) Brand 35 16 $377
Hydrocortisone Generic 30 14 $192

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Viraj Shroff-Mehta's medical specialty?
Dr. Viraj Shroff-Mehta practices Clinical & Laboratory Dermatological Immunology Physician in North Easton, MA.
Where does Dr. Viraj Shroff-Mehta practice?
Dr. Viraj Shroff-Mehta practices at 31 Roche Bros Way, North Easton, MA 023561032. Office phone: 5085353376.
What is Dr. Viraj Shroff-Mehta's NPI?
Dr. Viraj Shroff-Mehta's National Provider Identifier (NPI) is 1508838525, issued by NPPES.
Does Dr. Viraj Shroff-Mehta accept Medicare assignment?
Yes. Dr. Viraj Shroff-Mehta accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Viraj Shroff-Mehta commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.